Fraxodi

Fraxodi is a subcutaneous medication containing Nadroparin Calcium, used for anticoagulation therapy. This low-molecular-weight heparin helps prevent blood clots in various medical conditions.

Fraxodi is commonly used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also prescribed for patients undergoing surgery to reduce the risk of blood clots. Nadroparin Calcium, the active ingredient, works by inhibiting certain clotting factors in the blood.

Common effects of Fraxodi may include bruising, pain, or redness at the injection site. Some users might experience minor bleeding or allergic reactions. Always consult a healthcare provider if these effects persist or worsen.

Fraxodi should be handled with care, ensuring proper storage and administration. It is important to follow the prescribed dosage and monitor for any signs of unusual bleeding. Patients with a history of bleeding disorders or recent surgery should use this medication under medical supervision.

Fraxodi may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking.